» Articles » PMID: 37463111

Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer

Overview
Journal Thyroid
Date 2023 Jul 18
PMID 37463111
Authors
Affiliations
Soon will be listed here.
Citing Articles

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer.

Valerio L, Matrone A Explor Target Antitumor Ther. 2025; 6:1002291.

PMID: 40061140 PMC: 11886382. DOI: 10.37349/etat.2025.1002291.


Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives.

Zhang Y, Zheng W, Zhou S, Gu J, Yu Q, Zhu Y Cell Commun Signal. 2024; 22(1):460.

PMID: 39342195 PMC: 11439284. DOI: 10.1186/s12964-024-01837-x.